Genopathy
Gene-Disorder Association · Article
Gene
SV2A
Synaptic Vesicle Glycoprotein 2A
Disorder
Epilepsy
Manually curatedApproved treatment annotated
Association Review

In brief

The association between SV2A (Synaptic Vesicle Glycoprotein 2A) and Epilepsy is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 11
Compounds 1
Trials 82of 240 via SV2A compounds
Publications 5
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
SV2A

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Epilepsy

The disorder

11 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

240 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Literature

Reading

5 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

11 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access